Search results for "Geriatrics"

showing 10 items of 1388 documents

Safety and efficacy of montelukast as adjunctive therapy for treatment of asthma in elderly patients

2013

Asthma is a disease of all ages. This assumption has been challenged in the past, because of several cultural and scientific biases. A large body of evidence has accumulated in recent years to confirm that the prevalence of asthma in the most advanced ages is similar to that in younger ages. Asthma in the elderly may show similar functional and clinical characteristics to that occurring in young adults, although the frequent coexistence of comorbid conditions in older patients, together with age-associated changes in the human lung, may lead to more severe forms of the disease. Management of asthma in the elderly follows specific guidelines that apply to all ages, although most behaviors ar…

CyclopropanesMalePediatricsmedicine.medical_specialtyQuinolineDiseaseReviewSettore MED/10 - Malattie Dell'Apparato Respiratorioairway inflammationAcetatesSulfidesAnti-asthmatic AgentMaintenance therapyleukotriene antagonistmedicineAnti-Asthmatic AgentHumansAnti-Asthmatic AgentsYoung adultMontelukastAsthmaAgedAged 80 and overLeukotrienetreatmentAcetatebusiness.industryagingGeneral MedicineasthmaMiddle Agedmedicine.diseaseClinical trialleukotriene antagonistsPhysical therapyQuinolinesFemaleGeriatrics and GerontologybusinessHumanmedicine.drugClinical Interventions in Aging
researchProduct

Are the leukocyte telomere length attrition and telomerase activity alteration potential predictor biomarkers for sporadic TAA in aged individuals?

2014

A large variability in occurrence, complications, and age/gender manifestations characterizes individual susceptibility of sporadic thoracic aortic aneurysms (TAA), even in subjects with the same risk factor profiles. The reasons are poorly understood. On the other hand, TAA pathophysiology mechanisms remain unclear than those involved in abdominal aorta aneurysms. However, recent evidence is suggesting a crucial role of biological ageing in inter-individual risk variation of cardiovascular diseases, including sporadic TAA. Biological age rather than chronological age is a better predictor of vascular risk. Relevant assumptions support this concept. In confirming this evidence and our preli…

DNA ReplicationMaleTelomerasePathologymedicine.medical_specialtyAgingGenotypeEnzyme-Linked Immunosorbent AssayBiologyPolymerase Chain ReactionArticleAortic aneurysmRisk FactorsGenotypemedicineIn Situ Nick-End LabelingLeukocytesSporadic TAA. Biological ageing . Leukocyte telomere length attrition . Telomere activity alteration . Predictor TAAbiomarkersSettore MED/05 - Patologia ClinicaHumansGenetic Predisposition to DiseaseRisk factorTelomere ShorteningSettore MED/04 - Patologia GeneraleAortic Aneurysm ThoracicSettore MED/23 - Chirurgia CardiacaGeneral MedicineDNAMiddle AgedTelomeremedicine.diseaseMolecular medicineImmunohistochemistryPathophysiologyTelomereAgeingImmunologyFemaleGeriatrics and GerontologyBiomarkersAge (Dordrecht, Netherlands)
researchProduct

Italian guidelines on management of persons with multimorbidity and polypharmacy

2022

AbstractMultimorbidity and polypharmacy are emerging health priorities and the care of persons with these conditions is complex and challenging. The aim of the present guidelines is to develop recommendations for the clinical management of persons with multimorbidity and/or polypharmacy and to provide evidence-based guidance to improve their quality of care. The recommendations have been produced in keeping with the Grading of Recommendations Assessment, Development and Evaluation (GRADE). Overall, 14 recommendations were issued, focusing on 4 thematic areas: (1.) General Principles; (2.) target population for an individualized approach to care; (3.) individualized care of patients with mul…

Deprescribing; Frailty; Models of care; Multimorbidity; Patient-centered care; PolypharmacyAgingDeprescribingFrailtyHealth PrioritiesMultimorbidity · Polypharmacy · Frailty · Patient-centered care · Deprescribing · Models of careModels of carePatient-centered carePolypharmacyHumansSocio-culturaleMultimorbidityGeriatrics and Gerontology
researchProduct

The Importance of the Nurse’s Role in the Management of Complex Diabetic Outpatients: It is the Time to Manage Patient’s Multidimensions

2018

none

Diabetes Quality of lifemedicine.medical_specialtyUltrasound scanComorbiditylaw.invention03 medical and health sciences0302 clinical medicineClinical pathwaylawMedicineTherapeutic ReconciliationClinical ComplexityNursing AssessmentDepression (differential diagnoses)PolypharmacyClinical pharmacology030214 geriatricsbusiness.industryOutpatientDiabetes MellituGeneral MedicineSettore MED/45 - Scienze Infermieristiche Generali Cliniche E PediatrichePatient Care ManagementNutritionistChronic DiseasePhysical therapyGeriatric Depression ScalebusinessBioelectrical impedance analysisNeeds AssessmentBiomedical Journal of Scientific & Technical Research
researchProduct

The meanings older people give to their rehabilitation experience

2006

Promoting older people's ability to manage at home is important both for themselves and for society, but few studies have explored whether geriatric rehabilitation actually meets the needs of this heterogeneous group. The purpose of this study was to investigate the meanings that older adults attribute to their geriatric rehabilitation experiences. A group of 27 older adults in inpatient rehabilitation were interviewed during the programme and after returning home. Semi-structured interviews were analysed using a qualitative method, which identified three categories of meaning. In the category ‘sense of confidence with everyday life’, rehabilitation was perceived as facilitating everyday li…

DisappointmentHealth (social science)RehabilitationPsychotherapistGeriatric rehabilitationSocial Psychologymedicine.medical_treatmentmedia_common.quotation_subjectPublic Health Environmental and Occupational HealthArts and Humanities (miscellaneous)NursingmedicineMeaning (existential)Geriatrics and Gerontologymedicine.symptomOlder peopleEveryday lifePsychologyInpatient rehabilitationAutonomymedia_commonAgeing and Society
researchProduct

NMDA receptor antagonist treatment increases the production of new neurons in the aged rat hippocampus

2002

The production of new neurons declines during adulthood and persists, although at very low levels, in the aged hippocampus. Since neurogenesis in young adults has been related to learning and memory, its reduction may contribute to the age-related impairments in these abilities. Adrenalectomy (ADX) enhances neurogenesis in the aged hippocampus, although it also induces neuronal cell death. Since the administration of an NMDA receptor antagonist enhances neurogenesis in young adult rats without deleterious morphological effects, we have tested whether neurogenesis could be reactivated in aged rats. Our study shows that cell proliferation, cell death, neurogenesis and the number of radial gli…

Doublecortin Domain ProteinsAgingmedicine.medical_specialtyAntimetabolitesCell SurvivalCentral nervous systemHippocampusNerve Tissue ProteinsBiologyReceptors N-Methyl-D-AspartateInternal medicinemedicineAnimalsNeuronsCell DeathGeneral NeuroscienceNeuropeptidesNeurogenesisGlutamate receptorAntagonistAdrenalectomyNestinImmunohistochemistryRats Inbred F344RatsDoublecortinEndocrinologymedicine.anatomical_structure2-Amino-5-phosphonovalerateBromodeoxyuridinenervous systemDentate Gyrusbiology.proteinNMDA receptorFemaleNeurology (clinical)Geriatrics and GerontologyExcitatory Amino Acid AntagonistsMicrotubule-Associated ProteinsNeurogliaBiomarkersCell DivisionDevelopmental BiologyNeurobiology of Aging
researchProduct

"Eeny, Meeny, Miny, Moe": Prioritizing Medications on the Prescription as an Unexplored Avenue Towards Optimizing Geriatric Pharmacotherapy.

2018

Drug UtilizationMalemedicine.medical_specialtyMEDLINEDrug PrescriptionsPharmacotherapyDrug TherapyMedicineHumansMedical prescriptionIntensive care medicineGeriatric AssessmentGeneral NursingAgedPolypharmacyAged 80 and overbusiness.industryHealth PrioritiesHealth PolicyGeneral MedicineDrug UtilizationPolypharmacyFemaleFranceGeriatrics and GerontologybusinessJournal of the American Medical Directors Association
researchProduct

Highly purified chondroitin sulfate: a literature review on clinical efficacy and pharmacoeconomic aspects in osteoarthritis treatment

2020

AbstractOsteoarthritis (OA) is the most prevalent musculoskeletal disease and a major cause of negative relevant outcomes, associated with an ever-increasing societal burden. Pharmaceutical-grade chondroitin sulfate (CS) was repeatedly reported to reduce pain and improve function in patients with OA. This article aims to review the evidence for the role of highly purified (hp) CS (Condrosulf®, IBSA) in the treatment of OA. We collected and reported evidence concerning (1) efficacy of hpCS 800 mg/day in the treatment of OA affecting the knee, hand and hip; (2) efficacy and safety of hpCS 1200 mg/day also in the oral gel formulation; (3) the safety profile of hpCS; (4) the difference of hpCS …

DrugAgingmedicine.medical_specialtyChondroitin sulfateKnee Jointmedia_common.quotation_subjectChondroitin sulfate · Osteoarthritis · Knee osteoarthritis · Hip osteoarthritis · Hand osteoarthritis · Economic analysisOsteoarthritisReviewChondroitin sulfate A03 medical and health scienceschemistry.chemical_compound0302 clinical medicineInternal medicineOsteoarthritisHand osteoarthritismedicineHumansIn patientHip osteoarthritis030212 general & internal medicineClinical efficacyChondroitin sulfateEconomics Pharmaceuticalmedia_common030203 arthritis & rheumatologybusiness.industryAnti-Inflammatory Agents Non-SteroidalChondroitin SulfatesEconomic analysisMusculoskeletal diseaseOsteoarthritis Kneemedicine.diseaseSafety profileTreatment Outcomechemistryembryonic structuresKnee osteoarthritisGeriatrics and Gerontologybusiness
researchProduct

The impact of polypharmacy and drug interactions among the elderly population in Western Sicily, Italy.

2017

Aim: Primary endpoint was to report polypharmacy distribution in the general population vs ≥65 years old people and to examine the frequency of drug–drug interactions (DDIs) in the Health Local Unit of Palermo, Italy, in relationship with patients’ age. Methods: Drug prescription data for the year 2014 were extracted from the database of the Local Health Unit of Palermo Province, Italy. Patients were divided into five age groups (0–13, 14–64, 65–69, 70–74, and ≥75 year old). The detection of potential DDIs in polypharmacy profiles was performed with NavFarma software (Infologic srl, Padova, Italia), with DDI classification provided by tool Micromedex Drug Reax (Truven Health Analitics, Mich…

DrugMaleAgingPediatricsmedicine.medical_specialtyDatabases Factualmedia_common.quotation_subjectDrug interactionPopulationDrug prescription030204 cardiovascular system & hematologySettore MED/42 - Igiene Generale E Applicata03 medical and health sciences0302 clinical medicineDrug Utilization ReviewAge groupsElderly populationInternal medicinemedicineClinical endpointHumansDrug Interactions030212 general & internal medicineSettore SECS-S/05 - Statistica SocialeMedical prescriptioneducationSicilymedia_commonAgedPolypharmacyeducation.field_of_studyElderly populationbusiness.industrySignificant differenceAge FactorsMiddle AgedContraindicated drug-drug interactions.Population SurveillanceChronic DiseaseSettore BIO/14 - FarmacologiaPolypharmacyFemaleGeriatrics and GerontologybusinessAging clinical and experimental research
researchProduct

Trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009: a comparison of six cohorts

2012

Background Psychotropic drugs are extensively prescribed for the treatment of neuropsychiatric symptoms, despite modest efficacy and severe side effects. Aims We examined trends in psychotropic drug prescribing in Norwegian nursing homes from 1997 to 2009, in order to gain insight in practice development. Methods The study is a secondary data analysis of six cross-sectional nursing home studies conducted between 1997 and 2009. Patients aged >65 years were included. We compared the prevalence of psychotropic drugs (antipsychotics, anxiolytics, hypnotics, and antidepressants). Associations between prescription of psychotropics, and patients' age, gender, type of ward, and year of data collect…

DrugUnivariate analysismedicine.medical_specialtybusiness.industrymedia_common.quotation_subjectSecondary dataNorwegianLogistic regressionlanguage.human_languagePsychiatry and Mental healthPsychotropic drugConcomitantlanguageMedicineGeriatrics and GerontologyMedical prescriptionbusinessPsychiatrymedia_commonInternational Journal of Geriatric Psychiatry
researchProduct